Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non–ST-segment elevation acute coronary syndrome
- 1 August 2014
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 168 (2) , 189-196.e1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Incidence and Prognostic Significance of Thrombocytopenia Developed During Acute Coronary Syndrome in Contemporary Clinical PracticeCirculation, 2009
- Effect of Thrombocytopenia on Outcomes Following Treatment With Either Enoxaparin or Unfractionated Heparin in Patients Presenting With Acute Coronary SyndromesThe American Journal of Cardiology, 2007
- Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trialEuropean Heart Journal, 2007
- Impact of In-Hospital Acquired Thrombocytopenia in Patients Undergoing Primary Angioplasty for Acute Myocardial InfarctionThe American Journal of Cardiology, 2005
- Thrombocytopenia in Cardiovascular PatientsChest, 2005
- The SYNERGY trial: Study design and rationaleAmerican Heart Journal, 2002
- Prognostic Significance of Thrombocytopenia During Hirudin and Heparin Therapy in Acute Coronary Syndrome Without ST ElevationCirculation, 2001
- Clinical Significance of Thrombocytopenia During a Non–ST-Elevation Acute Coronary SyndromeCirculation, 1999
- Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarctionJACC, 1994
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993